The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124232513 12423251 3 F 20160926 20160601 20160930 PER US-PFIZER INC-2016261635 PFIZER 62.00 YR M Y 0.00000 20160930 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124232513 12423251 1 PS SUTENT SUNITINIB MALATE 1 50 MG, DAILY 21938 50 MG CAPSULE, HARD
124232513 12423251 2 SS SUTENT SUNITINIB MALATE 1 37.5 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) 21938 37.5 MG CAPSULE, HARD
124232513 12423251 3 C ACETAMINOPHEN AND CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Oral AS NEEDED (PARACETAMOL-300 MG-CODEINE PHOSPHATE-30 MG) (TAKE 1 TABLET TWICE A DAY ) 0 TABLET
124232513 12423251 4 C ALPRAZOLAM. ALPRAZOLAM 1 Oral 0.25 MG, AS NEEDED (1 TABLET TWICE A DAY) 0 .25 MG TABLET
124232513 12423251 5 C AMLODIPINE BESYLATE. AMLODIPINE BESYLATE 1 Oral 5 MG, 2X/DAY 0 5 MG TABLET BID
124232513 12423251 6 C CEPHALEXIN. CEPHALEXIN 1 Oral 500 MG, 4X/DAY 0 500 MG TABLET QID
124232513 12423251 7 C CLINDAMYCIN PHOSPHATE. CLINDAMYCIN PHOSPHATE 1 1 G, 2X/DAY (EXTREMELY GEL APPLY AND GENTLY MASSAGE INTO AFFECTED AREAS) 0 1 G GEL BID
124232513 12423251 8 C DEXILANT DEXLANSOPRAZOLE 1 Oral 60 MG, 1X/DAY (1 CAPSULE DAILY EVERYDAY MORNING BEFORE BREAKFAST) 0 60 MG PROLONGED-RELEASE CAPSULE QD
124232513 12423251 9 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Oral 25 MG, DAILY (12.5 MG ORAL CAPSULE TAKE 2 CAPSULES) 0 25 MG CAPSULE
124232513 12423251 10 C ACETAMINOPHEN W/HYDROCODONE ACETAMINOPHENHYDROCODONE 1 Oral (HYDROCODONE-5 MG, PARACETAMOL-325 MG) 0 TABLET
124232513 12423251 11 C LEVOTHYROXINE SODIUM. LEVOTHYROXINE SODIUM 1 Oral 75 UG, UNK (1 TABLET 30-60 MINUTES PRIOR TO BREAKFAST ON EMPTY STOMACH DO NOT LIE DOWN AFTER TAKE) 0 75 UG TABLET
124232513 12423251 12 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 40 MG, DAILY (TAKE 1 CAPSULE DAILY) 0 40 MG PROLONGED-RELEASE CAPSULE
124232513 12423251 13 C ONDANSETRON HCL ONDANSETRON HYDROCHLORIDE 1 Oral 4 MG, AS NEEDED (8 MG ORAL TABLET TAKE 0.5 TABLET EVERY 8 HOURS) 0 4 MG TABLET
124232513 12423251 14 C VALSARTAN. VALSARTAN 1 Oral 320 MG, UNK 0 320 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124232513 12423251 1 Metastatic renal cell carcinoma
124232513 12423251 3 Pain
124232513 12423251 13 Nausea

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
124232513 12423251 Activities of daily living impaired
124232513 12423251 Dyspnoea
124232513 12423251 Pain in extremity
124232513 12423251 Skin reaction

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124232513 12423251 2 20150506 0
124232513 12423251 3 20160127 0
124232513 12423251 4 20160330 0
124232513 12423251 6 20160719 0
124232513 12423251 7 20160719 0
124232513 12423251 10 20150312 0
124232513 12423251 13 20150507 0